Last updated on October 2018

A Long-Term Registry of Humira (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)


Brief description of study

This is a registry study to evaluate the long-term safety and effectiveness of adalimumab in patients with moderately to severely active UC who are treated as recommended in the product label.

Clinical Study Identifier: NCT01848561

Contact Investigators or Research Sites near you

Start Over

ABBVIE CALL CENTER

Hopital Beaujon /ID# 127395
Clichy, France
0.07miles
  Connect »

ABBVIE CALL CENTER

Hopital Bichat Claude Bernard /ID# 98641
Paris, France
3.95miles
  Connect »

ABBVIE CALL CENTER

Hopital Saint Antoine /ID# 141611
Paris, France
7.59miles
  Connect »